Wellington Management closes Biomedical Innovation Fund I at USD393m
Independent management and investment firm, Wellington Management (Wellington), has announced the final close of the Wellington Biomedical Innovation Fund I (the Fund). At the point of closure, the Fund was oversubscribed. The Fund will invest in private biotechnology companies focused on drug discovery and development, and seeking capital to advance